Donald Rothrauff, DPM
Podiatrist · Tell City, INNPI 1922110154
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,188 of the $1,973 with a category attached, or 60.2%. KCI USA, Inc. accounts for 77.2% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $981 and has fallen 92.0% since, to $78 in 2025.
Across 32 payments — averaging $61.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- KCI USA, Inc.$2K
- Organogenesis Inc.$150
- Smith+Nephew$62
- Reprise Biomedical, Inc.$38
- Melinta Therapeutics, LLC$38
- Nevro Corp.$35
- plus $127 from 6 others
What the payments were for
- Travel & lodging$78540%
- Food & beverage$1,18860%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| KCI USA, Inc. | 8 | $1,524 |
| Organogenesis Inc. | 7 | $150 |
| Smith+Nephew | 3 | $62 |
| Reprise Biomedical, Inc. | 2 | $38 |
| Melinta Therapeutics, LLC | 2 | $38 |
| Nevro Corp. | 2 | $35 |
| Urgo Medical North America, LLC | 2 | $31 |
| Convatec Inc. | 2 | $29 |
| Mimedx Group, Inc. | 1 | $21 |
| Reapplix Inc. | 1 | $17 |
| Solventum Corporation | 1 | $15 |
| Tactile Systems Technology Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SNAP$912
- Cavilon$554
- V.A.C. DERMATAC$554
- PREVENA$554
How this compares
$1,973 in reported general payments places this provider in the 60th percentile of 131 podiatrist providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 63 | $564 |
| Ketoconazole | 24 | $458 |
| Doxycycline Hyclate | 28 | $209 |
| Levofloxacin | 17 | $150 |
| Ciprofloxacin Hcl | 14 | $131 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Tell City
- Andrew RaderJasper$726K
- Anthony MillerIndianapolis$292K
- Corey GrohIndianapolis$57K
- Jeffrey StevensIndianapolis$56K
- James VestileTipton$44K
- Andrew KapsalisAvon$37K
- Scott HoffmanAvon$22K
- John RachoyMunster$21K
- Townsen KenningtonFort Wayne$20K
- Jared MoonCrown Point$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.